International Orthopaedics

, Volume 36, Issue 10, pp 1995–2002 | Cite as

Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol

  • Ettore Vulcano
  • Mark Gesell
  • Amanda Esposito
  • Yan Ma
  • Stavros G. Memtsoudis
  • Alejandro Gonzalez Della Valle
Original Paper

Abstract

Purpose

Multimodal thromboprophylaxis includes preoperative thromboembolic risk stratification and autologous blood donation, surgery performed under regional anaesthesia, postoperative rapid mobilisation, use of pneumatic compression devices and chemoprophylaxis tailored to the patient’s individual risk. We determined the 90-day rate of venous thromboembolism (VTE), other complications and mortality in patients who underwent primary elective hip and knee replacement surgery with multimodal thromboprophylaxis.

Methods

A total of 1,568 consecutive patients undergoing hip and knee replacement surgery received multimodal thromboprophylaxis: 1,115 received aspirin, 426 received warfarin and 27 patients received low molecular weight heparin and warfarin with or without a vena cava filter.

Results

The rate of VTE, pulmonary embolism, proximal deep vein thrombosis (DVT) and distal DVT was 1.2, 0.36, 0.45 and 0.36 %, respectively, in patients who received aspirin. The rates in those who received warfarin were 1.4, 0.9, 0.47 and 0.47 %, respectively. The overall 90-day mortality rate was 0.2 %.

Conclusions

Multimodal thromboprophylaxis in which aspirin is administered to low-risk patients is safe and effective following primary total joint replacement.

Notes

Acknowledgments

This study was partially funded by the generous donations of Mr. Glenn Bergenfield, The Sidney Milton and Leoma Simon Foundation, and Dr. and Mrs. Alberto Foglia.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH (2000) A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg 82:929–938PubMedGoogle Scholar
  2. 2.
    Falck-Ytter Y, Francis CW, Johanson NA et al (2012) Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e278S–e325SPubMedCrossRefGoogle Scholar
  3. 3.
    Treasure T, Chong LY, Sharpin C, Wonderling D, Head K, Hill J (2010) Developing guidelines for venous thromboembolism for The National Institute for Clinical Excellence: involvement of the orthopaedic surgical panel. J Bone Joint Surg Br 92(5):611–616PubMedCrossRefGoogle Scholar
  4. 4.
  5. 5.
    Butt AJ, McCarthy T, Kelly IP, Glynn T, McCoy G (2005) Sciatic nerve palsy secondary to postoperative haematoma in primary total hip replacement. J Bone Joint Surg Br 87:1465–1467PubMedCrossRefGoogle Scholar
  6. 6.
    Callaghan JJ, Dorr LD, Engh GA, Hanssen AD, Healy WL, Lachiewicz PF, Lonner JH, Lotke PA, Ranawat CS, Ritter MA, Salvati EA, Sculco TP, Thornhill TS, American College of Chest Physicians (2005) Prophylaxis for thromboembolic disease: recommendations from the American College of Chest Physicians–are they appropriate for orthopaedic surgery? J Arthroplasty 20:273–274PubMedCrossRefGoogle Scholar
  7. 7.
    Salvati EA, Sharrock NE, Westrich G, Potter HG, Gonzalez Della Valle A, Sculco TP (2007) The 2007 ABJS Nicolas Andry Award: three decades of clinical, basic, and applied research on thromboembolic disease after THA: rationale and clinical results of a multimodal prophylaxis protocol. Clin Orthop Relat Res 459:246–254PubMedCrossRefGoogle Scholar
  8. 8.
    Beksaç B, González Della Valle A, Anderson J, Sharrock NE, Sculco TP, Salvati EA (2007) Symptomatic thromboembolism after one-stage bilateral THA with a multimodal prophylaxis protocol. Clin Orthop Relat Res 463:114–119PubMedGoogle Scholar
  9. 9.
    Beksaç B, González Della Valle A, Salvati EA (2006) Thromboembolic disease after total hip arthroplasty: who is at risk? Clin Orthop Relat Res 453:211–224PubMedCrossRefGoogle Scholar
  10. 10.
    Sharrock NE, Go G, Harpel PC, Ranawat CS, Sculco TP, Salvati EA (1995) The John Charnley Award. Thrombogenesis during total hip arthroplasty. Clin Orthop Relat Res 319:16–27PubMedGoogle Scholar
  11. 11.
    Westrich GH, Farrell C, Bono JV, Ranawat CS, Salvati EA, Sculco TP (1999) The incidence of venous thromboembolism after total hip arthroplasty: a specific hypotensive epidural anesthesia protocol. J Arthroplasty 14(4):456–463PubMedCrossRefGoogle Scholar
  12. 12.
    Bae H, Westrich G, Sculco TP, Salvati EA, Reich LM (2001) The effect of preoperative donation of autologous blood on deep-vein thrombosis after total hip arthroplasty. J Bone Joint Surg Br 83(5):676–679PubMedCrossRefGoogle Scholar
  13. 13.
    González Della Valle A, Serota A, Go G, Sorriaux G, Sculco TP, Sharrock NE, Salvati EA (2006) Venous thromboembolism is rare with a multimodal prophylaxis protocol after total hip arthroplasty. Clin Orthop Relat Res 444:146–153PubMedCrossRefGoogle Scholar
  14. 14.
    Gesell M, Gonzalez Della Valle A, Haas S, Salvati E (2011) Safety and efficacy of multimodal thromboprophylaxis following elective total knee arthroplasty. A comparative study with selective versus routine use of coumadin for chemoprophylaxis. American Association of Hip and Knee Surgeons, 21st Annual Meeting, poster presentationGoogle Scholar
  15. 15.
    Memtsoudis SG, González Della Valle A, Besculides MC, Gaber L, Sculco TP (2008) In-hospital complications and mortality of unilateral, bilateral, and revision TKA: based on an estimate of 4,159,661 discharges. Clin Orthop Relat Res 466(11):2617-2627PubMedCrossRefGoogle Scholar
  16. 16.
    Asnis PD, Gardner MJ, Ranawat A, Leitzes AH, Peterson MG, Bass AR (2007) The effectiveness of warfarin dosing from a nomogram compared with house staff dosing. J Arthroplasty 22(2):213–218PubMedCrossRefGoogle Scholar
  17. 17.
    Parvizi J, Smith EB, Pulido L, Mamelak J, Morrison WB, Purtill JJ, Rothman RH (2007) The rise in the incidence of pulmonary embolus after joint arthroplasty: is modern imaging to blame? Clin Orthop Relat Res 463:107–113PubMedGoogle Scholar
  18. 18.
    Sharrock NE, Gonzalez Della Valle A, Go G, Lyman S, Salvati EA (2008) Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res 466(3):714–721PubMedCrossRefGoogle Scholar
  19. 19.
    Jameson SS, Charman SC, Gregg PJ, Reed MR, van der Meulen JH (2011) The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry. J Bone Joint Surg Br 93(11):1465–1470PubMedCrossRefGoogle Scholar
  20. 20.
    Auer RC, Schulman AR, Tuorto S, Gönen M, Gonsalves J, Schwartz L, Ginsberg MS, Fong Y (2009) Use of helical CT is associated with an increased incidence of postoperative pulmonary emboli in cancer patients with no change in number of fatal pulmonary emboli. J Am Coll Surg 208(5):871–878PubMedCrossRefGoogle Scholar
  21. 21.
    Poultsides LA, Gonzalez Della Valle A, Memtsoudis SG, Ma Y, Roberts T, Sharrock N, Salvati E (2012) Meta-analysis of cause of death following total joint replacement using different thromboprophylaxis regimens. J Bone Joint Surg Br 94(1):113–121PubMedCrossRefGoogle Scholar
  22. 22.
    Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW, American College of Chest Physicians (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):381S–453SPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Ettore Vulcano
    • 1
  • Mark Gesell
    • 1
  • Amanda Esposito
    • 2
  • Yan Ma
    • 3
  • Stavros G. Memtsoudis
    • 4
  • Alejandro Gonzalez Della Valle
    • 1
  1. 1.Department of Orthopaedic SurgeryHospital for Special Surgery and Weill Medical College of Cornell UniversityNew YorkUSA
  2. 2.Weill Medical College of Cornell UniversityNew YorkUSA
  3. 3.Department of BiostatisticsHospital for Special Surgery and Weill Medical College of Cornell UniversityNew YorkUSA
  4. 4.Department of AnesthesiologyHospital for Special Surgery and Weill Medical College of Cornell UniversityNew YorkUSA

Personalised recommendations